Creative Medical Technology Stock Alpha and Beta Analysis

CELZ Stock  USD 2.31  0.12  4.94%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Creative Medical Technology. It also helps investors analyze the systematic and unsystematic risks associated with investing in Creative Medical over a specified time horizon. Remember, high Creative Medical's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Creative Medical's market risk premium analysis include:
Beta
1.01
Alpha
(0.47)
Risk
7.06
Sharpe Ratio
(0.05)
Expected Return
(0.36)
Please note that although Creative Medical alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Creative Medical did 0.47  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Creative Medical Technology stock's relative risk over its benchmark. Creative Medical Tec has a beta of 1.01  . Creative Medical returns are very sensitive to returns on the market. As the market goes up or down, Creative Medical is expected to follow. At this time, Creative Medical's Book Value Per Share is fairly stable compared to the past year. Tangible Book Value Per Share is likely to rise to 7.39 in 2024, whereas Enterprise Value Over EBITDA is likely to drop (0.58) in 2024.

Enterprise Value

3.19 Million

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Creative Medical Backtesting, Creative Medical Valuation, Creative Medical Correlation, Creative Medical Hype Analysis, Creative Medical Volatility, Creative Medical History and analyze Creative Medical Performance.

Creative Medical Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Creative Medical market risk premium is the additional return an investor will receive from holding Creative Medical long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Creative Medical. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Creative Medical's performance over market.
α-0.47   β1.01

Creative Medical expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Creative Medical's Buy-and-hold return. Our buy-and-hold chart shows how Creative Medical performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Creative Medical Market Price Analysis

Market price analysis indicators help investors to evaluate how Creative Medical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Creative Medical shares will generate the highest return on investment. By understating and applying Creative Medical stock market price indicators, traders can identify Creative Medical position entry and exit signals to maximize returns.

Creative Medical Return and Market Media

The median price of Creative Medical for the period between Sat, Sep 14, 2024 and Fri, Dec 13, 2024 is 3.09 with a coefficient of variation of 21.41. The daily time series for the period is distributed with a sample standard deviation of 0.68, arithmetic mean of 3.2, and mean deviation of 0.54. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
Disposition of 10000000 shares by Ichim Thomas of Creative Medical at 0.004 subject to Rule 16b-3
09/26/2024
2
Are Pharma Stocks Harmful To Your Financial Health
10/10/2024
3
Creative Medical Technology Completes 1.6 Million Registered Direct Offering PHOENIX, October 23, 2024 Creative Medical Technology Holdings, Inc. finalized a se...
10/24/2024
4
Creative Medical Technology files to sell 0.83M shares of common stocks by selling shareholders - MSN
11/15/2024
5
CELZ stock touches 52-week low at 2.36 amid market challenges - Investing.com
12/03/2024
6
CELZ stock touches 52-week low at 2.21 amid market challenges - Investing.com
12/11/2024

About Creative Medical Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Creative or other stocks. Alpha measures the amount that position in Creative Medical Tec has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2023 2024 (projected)
Dividend Yield0.0043340.003853
Price To Sales Ratio721.02757.07

Creative Medical Upcoming Company Events

As portrayed in its financial statements, the presentation of Creative Medical's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Creative Medical's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Creative Medical's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Creative Medical. Please utilize our Beneish M Score to check the likelihood of Creative Medical's management manipulating its earnings.
29th of March 2024
Upcoming Quarterly Report
View
10th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
29th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with Creative Medical

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Additional Tools for Creative Stock Analysis

When running Creative Medical's price analysis, check to measure Creative Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Creative Medical is operating at the current time. Most of Creative Medical's value examination focuses on studying past and present price action to predict the probability of Creative Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Creative Medical's price. Additionally, you may evaluate how the addition of Creative Medical to your portfolios can decrease your overall portfolio volatility.